Friday, 23 June 2017

Merck’s Keytruda prolong life in lung cancer study

According to report, Merck & Co's
approved Keytruda lung cancer
treatment is said to provided superior
overall survival to chemotherapy.

This is confirmed
in a late-stage study of patients
with advanced disease whose
tumors produce a protein called
PD-L1 associated with increased
risk of the disease.

No comments:

Post a Comment

5 steps to use cold press to bring down fever in a child

Use cold press to bring down fever in a child 1. What you will do is to put some cool tap water in a bowl. If you like you can add a few...